Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 307INDUSTRY 115NIH 19OTHER_GOV 12NETWORK 2UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 78Breast 49Thoracic 29Head & Neck 16Lymphoid 14CNS 9Other hematologic neoplasm 7Gynecologic 6Genitourinary 4Dermatologic 4Sarcoma 3Other solid neoplasm 2Other neoplasm 2Tumor-Agnostic 1NET 1Myeloid 1Endocrine 1

Conditions

Extrapancreatic Neuroendocrine Tumor 1

Interventions

Thalidomide 1Temozolomide 1Tegafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Interventional × NET × Clear all
NCT03204032 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

ChineseAMS

Phase 2 Unknown
60 enrolled
EndocrineGastrointestinalNET

Extrapancreatic Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡